Abstract
We analyzed the genetic recombination pattern of the T-cell receptor beta-chain gene (TCR-beta) in order to identify clonal expansion of T-lymphocytes in 17 human T-lymphotropic virus type I (HTLV-I)-positive healthy carriers, 7 of them with abnormal features in the peripheral blood lymphocytes. Monoclonal or oligoclonal expansion of T-cells was detected in 5 of 7 HTLV-I-positive patients with abnormal lymphocytes and unconfirmed diagnosis by using PCR amplification of segments of TCR-beta gene, in a set of reactions that target 102 different variable (V) segments, covering all members of the 24 V families available in the gene bank, including the more recently identified segments of the Vbeta-5 and Vbeta-8 family and the two diversity beta segments. Southern blots, the gold standard method to detect T-lymphocyte clonality, were negative for all of these 7 patients, what highlights the low sensitivity of this method that requires a large amount of very high quality DNA. To evaluate the performance of PCR in the detection of clonality we also analyzed 18 leukemia patients, all of whom tested positive. Clonal expansion was not detected in any of the negative controls or healthy carriers without abnormal lymphocytes. In conclusion, PCR amplification of segments of rearranged TCR-beta is reliable and highly suitable for the detection of small populations of clonal T-cells in asymptomatic HTLV-I carriers who present abnormal peripheral blood lymphocytes providing an additional instrument for following up these patients with potentially higher risk of leukemia.
Highlights
Human T-lymphotropic virus type I (HTLV-I) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL)
We propose that PCR amplification of the rearranged T-cell receptor (TCR)-beta gene in order to detect clonal expansion of HTLV-I-infected T-cells would be a convenient method for detecting incipient clonal proliferation of infected cells
Blood samples were obtained from 17 patients identified as HTLV-I carriers during routine screening of blood donors
Summary
Human T-lymphotropic virus type I (HTLV-I) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL). It was in 1973 that ATLL, a previously unknown disease, was recognized in Japan [1]. In 1980, the causal relationship between ATLL and HTLV-. A mature T-cell non-Hodgkin’s lymphoma, ATLL, is characterized by a leukemia phase presenting circulating activated CD4+/CD25+ T-cells. The HTLV-I infection has a wide distribution [3] with major endemic foci in the Caribbean [4,5] and southern Japan [6]. The common routes of transmission are motherto-child, blood transfusion and sexual activity, emphasizing the impact of HTLV-I-related diseases on public health [12]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Brazilian Journal of Medical and Biological Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.